US Patent 9132281 Focused radiation for augmenting immune-based therapies against neoplasms
Patent 9132281 was granted and assigned to Johns Hopkins University on September, 2015 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 9132281 Focused radiation for augmenting immune-based therapies against neoplasms
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
